NASDAQ:GOVX - GeoVax Labs Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $8.00
  • Forecasted Upside: 90.48 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$4.20
▼ -0.41 (-8.89%)

This chart shows the closing price for GOVX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New GeoVax Labs Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GOVX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GOVX

Analyst Price Target is $8.00
▲ +90.48% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for GeoVax Labs in the last 3 months. The average price target is $8.00, with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 90.48% upside from the last price of $4.20.

This chart shows the closing price for GOVX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in GeoVax Labs.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/7/2021Maxim GroupReiterated RatingBuy$8.00Medium
11/19/2020Maxim GroupInitiated CoverageBuy$8.00Medium
(Data available from 7/23/2016 forward)
GeoVax Labs logo
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies and vaccines against cancers and infectious diseases using a novel vector vaccine platform. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever; Zika virus and malari; human immunodeficiency virus (HIV); as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Read More

Today's Range

Now: $4.20
Low: $4.10
High: $4.45

50 Day Range

MA: $5.01
Low: $4.11
High: $5.68

52 Week Range

Now: $4.20
Low: $2.56
High: $23.00

Volume

381,796 shs

Average Volume

1,198,876 shs

Market Capitalization

$26.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76

Frequently Asked Questions

What sell-side analysts currently cover shares of GeoVax Labs?

The following equities research analysts have issued research reports on GeoVax Labs in the last year: Maxim Group.
View the latest analyst ratings for GOVX.

What is the current price target for GeoVax Labs?

1 Wall Street analysts have set twelve-month price targets for GeoVax Labs in the last year. Their average twelve-month price target is $8.00, suggesting a possible upside of 87.8%. Maxim Group has the highest price target set, predicting GOVX will reach $8.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $8.00 for GeoVax Labs in the next year.
View the latest price targets for GOVX.

What is the current consensus analyst rating for GeoVax Labs?

GeoVax Labs currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GOVX will outperform the market and that investors should add to their positions of GeoVax Labs.
View the latest ratings for GOVX.

What other companies compete with GeoVax Labs?

How do I contact GeoVax Labs' investor relations team?

GeoVax Labs' physical mailing address is 1900 LAKE PARK DRIVE SUITE 380, SMYRNA GA, 30080. The company's listed phone number is (678) 384-7220 and its investor relations email address is [email protected] The official website for GeoVax Labs is www.geovax.com.